<VariationArchive RecordType="classified" VariationID="39973" VariationName="NM_004525.3(LRP2):c.12437del (p.Gly4146fs)" VariationType="Deletion" Accession="VCV000039973" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-20" DateCreated="2018-12-24" MostRecentSubmission="2023-11-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="48493" VariationID="39973">
      <GeneList>
        <Gene Symbol="LRP2" FullName="LDL receptor related protein 2" GeneID="4036" HGNC_ID="HGNC:6694" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q31.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="169127109" stop="169362534" display_start="169127109" display_stop="169362534" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="169983618" stop="170219121" display_start="169983618" display_stop="170219121" Strand="-" />
          </Location>
          <OMIM>600073</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004525.3(LRP2):c.12437del (p.Gly4146fs)</Name>
      <CanonicalSPDI>NC_000002.12:169152822:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q31.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="169152823" stop="169152823" display_start="169152823" display_stop="169152823" variantLength="1" positionVCF="169152822" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="170009333" stop="170009333" display_start="170009333" display_stop="170009333" variantLength="1" positionVCF="170009332" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>G4146fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.170009334del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.170009334del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.169152824del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.169152824del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012634.1" sequenceAccession="NG_012634" sequenceVersion="1" change="g.214790del">
            <Expression>NG_012634.1:g.214790del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004525.3" sequenceAccession="NM_004525" sequenceVersion="3" change="c.12437del" MANESelect="true">
            <Expression>NM_004525.3:c.12437del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004516.2" sequenceAccession="NP_004516" sequenceVersion="2" change="p.Gly4146fs">
            <Expression>NP_004516.2:p.Gly4146fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1300" sequenceAccession="LRG_1300">
            <Expression>LRG_1300:g.214790del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1300t1" sequenceAccession="LRG_1300t1">
            <Expression>LRG_1300t1:c.12437del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1300p1" sequenceAccession="LRG_1300p1" change="p.Gly4146fs">
            <Expression>LRG_1300p1:p.Gly4146fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="600073.0009" DB="OMIM" />
        <XRef Type="rs" ID="786205122" DB="dbSNP" />
        <XRef ID="CA261233" DB="ClinGen" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004525.3(LRP2):c.12437del (p.Gly4146fs) AND Donnai-Barrow syndrome" Accession="RCV000033107" Version="8">
        <ClassifiedConditionList TraitSetID="2599">
          <ClassifiedCondition DB="MedGen" ID="C1857277">Donnai-Barrow syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-11-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2012-11-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-12-24" MostRecentSubmission="2023-11-20">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23033978</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2599" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1497" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Faciooculoacousticorenal syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diaphragmatic hernia exomphalos absent corpus callosum hypertelorism myopia sensorineural deafness and proteinuria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Donnai-Barrow syndrome</ElementValue>
                <XRef ID="MONDO:0009104" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FOAR</ElementValue>
                <XRef Type="MIM" ID="222448" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1899" />
                <XRef ID="1899" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Donnai-Barrow syndrome (DBS) is characterized by typical craniofacial features (large anterior fontanelle, wide metopic suture, widow's peak, markedly widely spaced eyes, enlarged globes, downslanted palpebral fissures, posteriorly rotated ears, depressed nasal bridge, and short nose. Ocular complications include high myopia, retinal detachment, retinal dystrophy, and progressive vision loss. Additional common features include agenesis of the corpus callosum, sensorineural hearing loss, intellectual disability, and congenital diaphragmatic hernia and/or omphalocele. Both inter- and intrafamilial phenotypic variability are observed.</Attribute>
                <XRef ID="NBK1878" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301732</ID>
                <ID Source="BookShelf">NBK1878</ID>
              </Citation>
              <XRef ID="2143" DB="Orphanet" />
              <XRef ID="C1857277" DB="MedGen" />
              <XRef ID="MONDO:0009104" DB="MONDO" />
              <XRef Type="MIM" ID="222448" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="94632" SubmissionDate="2019-07-01" DateLastUpdated="2023-11-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600073.0009_DONNAI-BARROW SYNDROME" title="LRP2, 1-BP DEL, NT12437_DONNAI-BARROW SYNDROME" />
        <ClinVarAccession Accession="SCV000056888" DateUpdated="2023-11-20" DateCreated="2013-04-04" Type="SCV" Version="7" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-11-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 36-year-old man studied as part of a cohort of individuals with intellectual disability, de Ligt et al. (2012) identified a heterozygous de novo mutation in the LRP2 gene, a 1-bp deletion at position 12437, resulting in a frameshift (Gly4146GlufsTer2). The patient had had seizures from the first day of life and showed developmental delay. As an adult, he was slender but of normal stature and head circumference. Facial dysmorphism included hypertelorism, mild scaphocephaly, deeply set eyes, prominent cheek bones, over-folded helices with bilateral ear tags, broad nasal bridge, and large mouth with downturned corners and a full lower lip; he also had poor vision. The man was diagnosed with Donnai-Barrow syndrome (DBS; 222448) after an additional mutation was detected in the LRP2 gene: a rare, paternally inherited 6160G-A transition, resulting in an asp2054-to-asn (D2054N) substitution (600073.0010).</Attribute>
              <Citation>
                <ID Source="PubMed">23033978</ID>
              </Citation>
              <XRef DB="OMIM" ID="222448" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LRP2" />
          </GeneList>
          <Name>LRP2, 1-BP DEL, NT12437</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, NT12437</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600073.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DONNAI-BARROW SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="94632" TraitType="Disease" MappingType="Name" MappingValue="DONNAI-BARROW SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C1857277" Name="Donnai-Barrow syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

